Metropolitan Life Insurance Company (MetLife)’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-33,953
| Closed | -$1.78M | – | 2616 |
|
|
2020
Q3 | $1.78M | Sell |
33,953
-1,857
| -5% | -$76.9K | 0.03% | 458 |
|
|
2020
Q2 | $1.19M | Buy |
35,810
+1,420
| +4% | +$45.2K | 0.02% | 630 |
|
|
2020
Q1 | $935K | Buy |
34,390
+3,341
| +11% | +$93K | 0.02% | 708 |
|
|
2019
Q4 | $613K | Sell |
31,049
-972
| -3% | -$15.5K | 0.01% | 1200 |
|
|
2019
Q3 | $415K | Buy |
32,021
+596
| +2% | +$7.2K | 0.01% | 1412 |
|
|
2019
Q2 | $391K | Hold |
31,425
| – | – | 0.01% | 1458 |
|
|
2019
Q1 | $457K | Buy |
31,425
+5,094
| +19% | +$65.1K | 0.01% | 1361 |
|
|
2018
Q4 | $291K | Buy |
26,331
+1,261
| +5% | +$17.6K | 0.01% | 1566 |
|
|
2018
Q3 | $659K | Hold |
25,070
| – | – | 0.01% | 1171 |
|
|
2018
Q2 | $513K | Hold |
25,070
| – | – | 0.01% | 1295 |
|
|
2018
Q1 | $455K | Buy |
25,070
+566
| +2% | +$9.44K | 0.01% | 1340 |
|
|
2017
Q4 | $342K | Sell |
24,504
-23,066
| -48% | -$312K | ﹤0.01% | 1539 |
|
|
2017
Q3 | $880K | Hold |
47,570
| – | – | 0.01% | 1328 |
|
|
2017
Q2 | $804K | Buy |
47,570
+1,393
| +3% | +$21.2K | 0.01% | 1370 |
|
|
2017
Q1 | $616K | Sell |
46,177
-1,846
| -4% | -$28.9K | ﹤0.01% | 1521 |
|
|
2016
Q4 | $723K | Hold |
48,023
| – | – | 0.01% | 1492 |
|
|
2016
Q3 | $561K | Hold |
48,023
| – | – | ﹤0.01% | 1637 |
|
|
2016
Q2 | $519K | Buy |
48,023
+2,141
| +5% | +$22.1K | ﹤0.01% | 1663 |
|
|
2016
Q1 | $424K | Hold |
45,882
| – | – | ﹤0.01% | 1682 |
|
|
2015
Q4 | $681K | Buy |
45,882
+5,412
| +13% | +$90.6K | 0.01% | 1421 |
|
|
2015
Q3 | $664K | Hold |
40,470
| – | – | ﹤0.01% | 1439 |
|
|
2015
Q2 | $923K | Buy |
40,470
+3,104
| +8% | +$61.8K | 0.01% | 1346 |
|
|
2015
Q1 | $568K | Hold |
37,366
| – | – | ﹤0.01% | 1486 |
|
|
2014
Q4 | $450K | Hold |
37,366
| – | – | ﹤0.01% | 1833 |
|
|
2014
Q3 | $424K | Hold |
37,366
| – | – | ﹤0.01% | 1818 |
|
|
2014
Q2 | $451K | Hold |
37,366
| – | – | ﹤0.01% | 1908 |
|
|
2014
Q1 | $435K | Hold |
37,366
| – | – | ﹤0.01% | 1912 |
|
|
2013
Q4 | $661K | Hold |
37,366
| – | – | ﹤0.01% | 1615 |
|
|
2013
Q3 | $538K | Hold |
37,366
| – | – | ﹤0.01% | 1714 |
|
|
2013
Q2 | $563K | Buy |
+37,366
| New | +$493K | ﹤0.01% | 1622 |
|
Metropolitan Life Insurance Company (MetLife)'s MNTA Position: Q4 2020 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 33,953 shares — an estimated $1.78M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $1.78M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 33,953 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1.78M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Momenta Pharmaceuticals, Inc. position peaked at $1.78M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2020, filed 16 Feb 2021.